These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23032483)

  • 1. Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.
    Okami N; Narasimhan P; Yoshioka H; Sakata H; Kim GS; Jung JE; Maier CM; Chan PH
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):106-14. PubMed ID: 23032483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1.
    Verma R; Mishra V; Gupta K; Sasmal D; Raghubir R
    J Neurosci Res; 2011 Nov; 89(11):1849-58. PubMed ID: 21826699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage.
    Lee CH; Park OK; Yoo KY; Byun K; Lee B; Choi JH; Hwang IK; Kim YM; Won MH
    J Neurol Sci; 2011 Jan; 300(1-2):120-9. PubMed ID: 20880548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways.
    Guan QH; Pei DS; Zhang QG; Hao ZB; Xu TL; Zhang GY
    Brain Res; 2005 Feb; 1035(1):51-9. PubMed ID: 15713276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
    Morrison A; Yan X; Tong C; Li J
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose alcohol consumption protects against transient focal cerebral ischemia in mice: possible role of PPARγ.
    Sun H; Xiong W; Arrick DM; Mayhan WG
    PLoS One; 2012; 7(7):e41716. PubMed ID: 22848576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells.
    Yoon SY; Park JS; Choi JE; Choi JM; Lee WJ; Kim SW; Kim DH
    Neurobiol Dis; 2010 Nov; 40(2):449-55. PubMed ID: 20655383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinase after transient forebrain ischemia in mice.
    Takagi Y; Nozaki K; Sugino T; Hattori I; Hashimoto N
    Neurosci Lett; 2000 Nov; 294(2):117-20. PubMed ID: 11058801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.
    Fatehi-Hassanabad Z; Tasker RA
    Neurotox Res; 2011 Apr; 19(3):462-71. PubMed ID: 20524105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered PPARgamma expression and activation after transient focal ischemia in rats.
    Victor NA; Wanderi EW; Gamboa J; Zhao X; Aronowski J; Deininger K; Lust WD; Landreth GE; Sundararajan S
    Eur J Neurosci; 2006 Sep; 24(6):1653-63. PubMed ID: 17004929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.
    Chu K; Lee ST; Koo JS; Jung KH; Kim EH; Sinn DI; Kim JM; Ko SY; Kim SJ; Song EC; Kim M; Roh JK
    Brain Res; 2006 Jun; 1093(1):208-18. PubMed ID: 16696956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt.
    Xing B; Xin T; Hunter RL; Bing G
    J Neuroinflammation; 2008 Jan; 5():4. PubMed ID: 18205920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation.
    Wu JS; Cheung WM; Tsai YS; Chen YT; Fong WH; Tsai HD; Chen YC; Liou JY; Shyue SK; Chen JJ; Chen YE; Maeda N; Wu KK; Lin TN
    Circulation; 2009 Mar; 119(8):1124-34. PubMed ID: 19221220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection.
    Thouennon E; Cheng Y; Falahatian V; Cawley NX; Loh YP
    J Neurochem; 2015 Aug; 134(3):463-70. PubMed ID: 25940785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.